Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet Healthcare (NYSE: THC) reported strong Q4 2024 results with net income of $318 million ($3.32 per diluted share) and Adjusted EBITDA of $1.048 billion. The company's Ambulatory Care segment showed impressive growth with Q4 Adjusted EBITDA increasing 14.2% to $530 million.
Key financial highlights include Q4 net operating revenues of $5.072 billion, down from $5.379 billion in Q4 2023 due to hospital divestitures, offset by strong same-facility revenue growth. For full-year 2024, the company achieved net income of $3.2 billion, including a $2.916 billion pre-tax gain from hospital divestitures.
The company's 2025 outlook projects net operating revenues between $20.6-21.0 billion and Adjusted EBITDA of $3.975-4.175 billion. Tenet also reported significant deleveraging, with its net debt to Adjusted EBITDA ratio improving to 2.54x from 3.89x year-over-year.
Tenet Healthcare (NYSE: THC) has announced it will release its fourth quarter 2024 financial results before market opening on Wednesday, February 12, 2025. The company will host a conference call at 9:00 a.m. CT (10:00 a.m. ET) on the same day to discuss the results. Investors can access both the live webcast and audio archive of the call through the investor relations section of Tenet's website.
Tenet Healthcare (NYSE: THC) reported strong Q3 2024 results with net income of $472 million ($4.89 per diluted share), including a $209 million after-tax gain from hospital divestitures. Consolidated Adjusted EBITDA reached $978 million, up 14.5% year-over-year. The company's Ambulatory Care segment showed impressive growth with Adjusted EBITDA of $439 million, increasing 18.6%. Based on strong performance, Tenet raised its FY 2024 Adjusted EBITDA outlook to $3.9-4.0 billion, a $50 million increase. The company demonstrated robust cash flow generation with $2.378 billion from operating activities for the first nine months of 2024.
Tenet Healthcare (NYSE: THC) has announced its upcoming participation in the UBS Global Healthcare Conference. The presentation is scheduled for Tuesday, November 12, 2024, at 12:30 p.m. Eastern time. Investors and interested parties can access a live webcast of the presentation through Tenet's investor relations website. The presentation recording will remain available for replay on the company's website for 30 days following the event.
Tenet Healthcare (NYSE: THC) has announced it will release its third quarter 2024 financial results before the market opens on Tuesday, October 29, 2024. Following the release, the company will host a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time) to discuss the results.
Investors and interested parties can access a live webcast and audio archive of the conference call through the investor relations section of Tenet's website at www.tenethealth.com/investors. This announcement provides shareholders and analysts with a specific date to anticipate the company's latest financial performance update.
Tenet Healthcare (NYSE: THC) has completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham to Orlando Health. The transaction includes five hospitals: Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Princeton Baptist Medical Center, Shelby Baptist Medical Center, and Walker Baptist Medical Center, along with other related operations.
As part of the deal, Tenet's subsidiary, Conifer Health Solutions, has entered into a ten-year contract to provide comprehensive revenue cycle management services for these operations. This sale aligns with previously disclosed terms and marks a significant change in Tenet's portfolio in the Birmingham area.
Tenet Healthcare (NYSE: THC) will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, starting at 9:30 a.m. Eastern time. This event will be live webcasted and archived audio can be accessed via the investor relations section on Tenet's website, www.tenethealth.com/investors. The replay will be available for 30 days.
Tenet Healthcare (NYSE: THC) has announced a definitive agreement to sell its 70% majority ownership in Brookwood Baptist Health in Birmingham to Orlando Health for $910 million in cash. The deal includes five hospitals and related operations, with after-tax proceeds of approximately $790 million. Tenet's Conifer Health Solutions will enter a new 10-year contract for revenue cycle management services. The transaction is expected to complete in fall 2024, subject to regulatory approvals. Tenet estimates a pre-tax book gain of $375 million from this deal. For the twelve months ended June 30, 2024, Tenet's equity interest in Brookwood Baptist Health generated $12 million in pre-tax income and $60 million in Adjusted EBITDA less non-controlling interest. Tenet has reaffirmed its FY24 Adjusted EBITDA Outlook.
Tenet Healthcare (NYSE: THC) reported strong Q2 2024 results, surpassing expectations. Key highlights include:
- Net income of $259 million or $2.64 per diluted share
- Adjusted EBITDA of $945 million, up 12.1% year-over-year
- Ambulatory Care Adjusted EBITDA of $447 million, up 20.8%
- New $1.5 billion share repurchase program authorized
The company raised its FY 2024 outlook, now expecting Adjusted EBITDA of $3.825-$3.975 billion and Free Cash Flow of $1.100-$1.350 billion. Strong performance was driven by volume and revenue growth, improved operating efficiency, and portfolio transformation.
Tenet Healthcare (NYSE: THC) will release its second quarter 2024 financial results on July 24, 2024, by 6:00 a.m. Central Time (CT).
This will be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time), which will be available via live webcast and audio archive on Tenet’s investor relations section of their website.